2023-10-16 | TSX:GUD | Press Release | Knight Therapeutics I

(2023-10-16 | TSX:GUD) Knight Therapeutics Announces CMED Price Approval of Minjuvi® (tafasitamab) in Brazil

Related Keywords

Portuguesa , Estado Do Rio , Brazil , Montreal , Quebec , Canada , United States , Japan , United Kingdom , Brazilian , American , America , Danielle Le , Knight Closecurlyquote , Samira Sakhia , Cristiane Coelho , Biotoscana Farma , Morphosys Incyte , Pemigatinib Pemazyre , Knight Therapeutics Inc , Xencor Inc , Drugs Market Regulation Chamber , Incyte Corporation , Drug Administration , United Medical Ltd , Head Of The Hematology Department , Therapeutics Inc , Nacional De Vigil , Market Authorization , Hematology Department , Portuguesa Hospital , Latin America , Knight Therapeutics President , Knight Therapeutics Brazil General , Antibody Dependent Cell Mediated Cytotoxicity , Antibody Dependent Cellular Phagocytosis , Prescribing Information , Region Europe , Latin American , United Medical , Knight Therapeutics , Annual Report , Annual Information Form , Healthcare 37 , Can 7 , Usa 8 ,